Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 117,059.7 | 101,858.5 | 92,994.4 | 84,523.9 | 72,912.3 | 56,591.3 | 40,203.2 | 23,129.3 |
| Revenue growth | 14.9% | 9.5% | 10.0% | 15.9% | 28.8% | 40.8% | 73.8% | 122.0% |
| Cost of goods sold | 101,605.6 | 87,452.2 | 79,631.9 | 74,944.4 | 63,518.1 | 47,899.2 | 33,973.8 | 19,647.0 |
| Gross profit | 15,454.1 | 14,406.3 | 13,362.5 | 9,579.6 | 9,394.2 | 8,692.1 | 6,229.5 | 3,482.3 |
| Gross margin | 13.2% | 14.1% | 14.4% | 11.3% | 12.9% | 15.4% | 15.5% | 15.1% |
| Sales and marketing | 5,089.2 | 4,284.3 | 3,323.9 | 3,240.5 | 2,978.6 | 2,837.7 | 2,089.3 | 1,164.1 |
| Research and development | 1,517.3 | 1,221.3 | 1,568.1 | 2,000.9 | 1,808.5 | 1,563.6 | 1,076.5 | 671.0 |
| General and administrative | 4,189.7 | 3,748.5 | 4,064.3 | 2,674.2 | 2,447.7 | 1,941.1 | 1,301.5 | 967.5 |
| EBITA | 5,636.8 | 5,929.1 | 5,094.6 | 2,422.0 | 3,009.0 | 3,000.2 | 2,276.1 | 1,021.2 |
| EBITA margin | 4.8% | 5.8% | 5.5% | 2.9% | 4.1% | 5.3% | 5.7% | 4.4% |
| Amortization of intangibles | 12.1 | 36.5 | 15.8 | 47.8 | 340.8 | 364.0 | 289.6 | 250.2 |
| EBIT | 5,624.7 | 5,892.6 | 5,078.8 | 2,374.1 | 2,668.2 | 2,636.2 | 1,986.5 | 771.0 |
| EBIT margin | 4.8% | 5.8% | 5.5% | 2.8% | 3.7% | 4.7% | 4.9% | 3.3% |
| Pre-tax income | 5,873.3 | 7,019.4 | 4,942.8 | 2,747.1 | 2,540.9 | 2,666.1 | 2,050.5 | 1,060.3 |
| Income taxes | 1,222.7 | 1,130.0 | 983.6 | 566.6 | 626.1 | 601.8 | 457.7 | -245.0 |
| Tax rate | 20.8% | 16.1% | 19.9% | 20.6% | 24.6% | 22.6% | 22.3% | |
| Net income | 4,681.1 | 5,907.0 | 4,016.8 | 2,128.8 | 1,949.7 | 2,036.8 | 1,589.7 | 841.3 |
| Net margin | 4.0% | 5.8% | 4.3% | 2.5% | 2.7% | 3.6% | 4.0% | 3.6% |
| |
| Diluted EPS | $33.74 | $42.79 | $29.52 | $15.20 | $15.51 | $16.19 | $13.23 | $7.00 |
| Shares outstanding (diluted) | 138.7 | 138.0 | 136.1 | 140.1 | 125.7 | 125.8 | 120.2 | 120.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|